# Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

> **NCT05868317** · PHASE2 · UNKNOWN · sponsor: **Salah Azaïz Cancer Institute** · enrollment: 70 (estimated)

## Conditions studied

- Rectal Cancer
- Locally Advanced

## Interventions

- **DRUG:** Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT05868317
- **Lead sponsor:** Salah Azaïz Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05868317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05868317, "Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05868317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*